Antiviral Therapy publishes original research that focuses on strategic issues in the field, from basic science through study design and safety monitoring, to the results of clinical trials in all phases.
Why submit to Antiviral Therapy?
♦ Antiviral Therapy is a high-ranked peer-reviewed journal (ISI® impact factor of 3.02) that publishes articles on the development of antiviral agents and vaccines, and the treatment of all viruses
♦ Our international Editorial Board includes leaders in virology, with expertise across all major research areas, ensuring high-quality standards for our publication
♦ Non-commissioned articles are published immediately following acceptance on this website and indexed on PubMed and CrossRef
This section of our website includes helpful information to guide new authors through the process of preparing a manuscript for submission and includes valuable information for returning authors. Please read our Editorial Policy and Author Guidelines before submitting your manuscript.
If you have any further questions regarding our publishing process, author guidelines, submission or support, please contact our editorial office at email@example.com.